{HEAD ~ This invention} relates generally to modulators of {TAIL ~ chemokine receptor activity}, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and prevention of inflammatory diseases, allergic and autoimmune diseases, and in particular, asthma, rheumatoid arthritis, atherosclerosis, and multiple sclerosis 
{ HEAD ~ This invention } relates generally to modulators of { TAIL ~ chemokine receptor activity } , pharmaceutical compositions containing the same , and methods of using the same as agents for treatment and prevention of inflammatory diseases , allergic and autoimmune diseases , and in particular , asthma , rheumatoid arthritis , atherosclerosis , and multiple sclerosis
HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH